Welcome to the New Face of Oncology
Introducing the new ONCOLOGY, with a new team and a new look.
Approaching Use of CDK4/6 Inhibitors in Metastatic HR+, HER2- Breast Cancer
An otherwise healthy 58-year-old woman with a history of breast cancer presents to the clinic with newly diagnosed metastatic disease; eventual abdominal CT showed a mass in the transverse colon with ascites and peritoneal nodularity. What is the best initial systemic treatment for her?
A Patient With EGFR-Mutated Lung Cancer Progressing on Erlotinib: Evaluating for a T790M Mutation With Limited Tissue
Due to the high rate of EGFR T790M mutations seen in NSCLC patients, the thoracic tumor board recommends genomic testing for this alteration; read our case of a 69-year-old woman with metastatic disease.
2 Commerce Drive Cranbury, NJ 08512